Commonwealth Equity Services
DNLI icon

Commonwealth Equity Services’s Denali Therapeutics DNLI Stock Holding History

Commonwealth Equity Services’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,636
Closed -$206K – 3729
2021
Q4 		$206K Buy
4,636
+472
+11% +$22.4K ﹤0.01% 3280
2021
Q3 		$210K Buy
4,164
+195
+5% +$11K ﹤0.01% 3235
2021
Q2 		$311K Hold
3,969
– – ﹤0.01% 2861
2021
Q1 		$226K Hold
3,969
– – ﹤0.01% 3027
2020
Q4 		$332K Buy
+3,969
New +$240K ﹤0.01% 2481

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return